Diabetes - Islet Patophysiology
1 – 10 of 154
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Prevention of Pancreatic β-Cell Failure in Type 2 Diabetes. By Targeting a Mitochondrial Voltage Gated Channel 1 and a Novel class of GPCRs.
- 2018
- MafA expression preserves immune homeostasis in human and mouse islets
- Intracellular non-GPI anchored isoform of CD59 is responsible for facilitating of insulin secretion from pancreatic beta-cells
- Activation of imidazoline receptor I2, and improved pancreatic β-cell function in human islets
- Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes article
- Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production
- Novel subgroups of adult-onset diabetes and their association with outcomes : A data-driven cluster analysis of six variables
- 2017
- Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
- Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
- Metabolite profiling of LADA challenges the view of a metabolically distinct subtype